Cancer immunotherapy | The PD-L1 pathway

PD-L1/PD-1 pathway: a security checkpoint

Unleashing the T-cell army | Cancer immunotherapy at Roche

Drawn to Science | T-cell bispecific antibodies

Monoclonal antibodies in medicine

What are antibody-drug conjugates and how do they work against cancer?

Izglītojoša podkāsta saruna par krūts vēža skrīningu un ģimenes ārstu lomu šajā procesā

Die Rolle von Breast Cancer Care Nurses und Cancer Nurses in der onkologischen Pflege: Harald Titzer

Prof. Rovin on B-cell depletion in Lupus Nephritis

A closer look at Roche's TAGS technology

Saruna "Vai ir iespējams darba laikā veikt nozīmīgu veselības pārbaudi?"

Saruna par krūts vēža diagnozi

Prof. Rovin on how to minimise the use of glucocorticoids in Lupus Nephritis

#CitasImperdibles: Detectar el cáncer de mama en LATAM puede ser cuestión de prioridades.

Roche BeLux Patient Week 2024

Advancing Care for Breast Cancer Patients: The Power of Teamwork in Healthcare | #HealthcareMatters

Prof. Rovin & Dr. Mejia-Vilet on imagining the ideal endpoint in Lupus Nephritis clinical studies

Prof. Rovin & Dr. Mejia-Vilet on how biopsies are used in treating patients with Lupus Nephritis

In Conversation with Lance Little and Kent Kost

Dr. Parodis on the need of early effective therapies in Lupus Nephritis

Prof. Rovin & Dr. Mejia-Vilet on what kidney outcomes matter in Lupus Nephritis